(EBCTCG), E. B. C. T. C. G., Malmström, P., Lund University, F. o. M., & Lund University, F. o. M. (2018). Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer. The Lancet. Oncology, 19(1), 27. https://doi.org/10.1016/S1470-2045(17)30777-5
Chicago Style (17th ed.) Citation(EBCTCG), Early Breast Cancer Trialists Collaborative Group, Per Malmström, Faculty of Medicine Lund University, and Faculty of Medicine Lund University. "Long-term Outcomes for Neoadjuvant Versus Adjuvant Chemotherapy in Early Breast Cancer." The Lancet. Oncology 19, no. 1 (2018): 27. https://doi.org/10.1016/S1470-2045(17)30777-5.
MLA (9th ed.) Citation(EBCTCG), Early Breast Cancer Trialists Collaborative Group, et al. "Long-term Outcomes for Neoadjuvant Versus Adjuvant Chemotherapy in Early Breast Cancer." The Lancet. Oncology, vol. 19, no. 1, 2018, p. 27, https://doi.org/10.1016/S1470-2045(17)30777-5.
